retatrutide parkinson Diabetes Dialogue: Reduces Body Weight 28.7% in Phase 3 Trial retatrutide parkinson clinical trial 💊

Incretins, such as GLP-1 and glucose-dependent insulinotropic polypeptide (GIP), are secreted by entero-endocrine cells of the gastrointestinal tract to stimulate glucose-dependent insulin secretion and beta-cell proliferation

Deal trajectory: Novo paid $200M upfront to license a triple agonist (UBT251) from United Laboratories (China) in March 2025 directly targeting the same GLP-1/GIP/GCGR space as Lillys retatrutide

Celebrate Vitamins az n sznpadra s letmdjra szabott kombincikat knl: Kezdknek: kezdje rghat vagy folykony tpszerekkel, hogy a tpllkkiegszts egyszer s kmletes legyen

References: Polito, Rick

Eli Lilly and Novo Nordisk are aggressively pushing back on this approach in lawsuits, arguing that companies are mass-prescribing compounded versions of their drugs under the pretext of personalizing them